Back to Oncology
Oncologyv1999Evidence-Based

Fong Clinical Risk Score for Colorectal Cancer Recurrence

Predicts recurrence and survival risk for colorectal cancer patients with liver metastases after hepatic resection. Developed from analysis of 1,001 consecutive cases to identify high-risk patients who may benefit from adjuvant therapy or closer surveillance.

Clinical Input Parameters

ng/mL
cm
Clinical Assessment
Awaiting Parameters
fong score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Fong Clinical Risk Score for Colorectal Cancer Recurrence is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of points: Node-positive primary (1 point) + Disease-free interval <12 months (1 point) + Multiple tumors (1 point) + CEA >200 ng/mL (1 point) + Largest tumor >5 cm (1 point)

Clinical Pearls & Practice Notes

  • Developed from analysis of 1,001 consecutive patients undergoing hepatic resection for colorectal liver metastases at Memorial Sloan-Kettering Cancer Center (1985-1998)
  • Not intended to exclude patients from surgery but to stratify risk and guide treatment decisions
  • Patients with scores 0-2 have favorable outcomes and should be considered for resection
  • Patients with scores ≥3 should be considered for experimental adjuvant therapy
  • The score helps predict both overall survival and disease-free survival
  • Useful for patient counseling, surveillance planning, and clinical trial stratification
  • Validated in multiple independent cohorts and remains widely used despite advances in systemic therapy

Evidence & Literature Citations

  1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309-318.
  2. Mala T, Bohler G, Mathisen O, Bergan A, Soreide O. Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg. 2002;26(11):1348-1353.
  3. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ. The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg. 2004;139(11):1168-1172.
  4. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 1996;77(7):1254-1262.

Score Interpretation Ranges

Score 00 – 0 pts

Excellent prognosis

Score 11 – 1 pts

Good prognosis

Score 22 – 2 pts

Moderate prognosis

Score 33 – 3 pts

Poor prognosis

Score 44 – 4 pts

Very poor prognosis

Score 55 – 5 pts

Extremely poor prognosis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.